ArticleTobacco control2022
Tobacco retail licencing systems in Europe.
Article in Tobacco control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Proximity and density of tobacco retail locations to Kentucky schools and the relationship to youth perceptions of harm and susceptibility to e-cigarette use.BMC public health · 2026Article
- Exploring small retailers' perspectives on selling tobacco after the tripling of Tasmania's tobacco licence fee.Tobacco control · 2026Article
- Tobacco endgame goals and measures in Europe: current status and future directions.Tobacco control · 2025Article
- Global policy scan of commercial combustible tobacco product retailing regulations by WHO region.Tobacco control · 2025Article
- Impact of regulatory tightening of the Hungarian tobacco retail market on availability, access and cigarette smoking prevalence of adolescents.Tobacco control · 2025Article
- Geographical differences in the financial impacts of different forms of tobacco licence fees on small retailers in Scotland.Tobacco control · 2025Article
- Area-level sociodemographic differences in tobacco availability examined with nationwide tobacco product retail licence data in Finland.Tobacco control · 2024Article
- Towards stronger tobacco control policies to curb the smoking epidemic in Spain.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024Review
- Article
- Ex ante evaluation of the impact of tobacco control policy measures aimed at the point of sale in the Netherlands.Tobacco control · 2023Article
- The association between objectively measured exposure to tobacco outlets and smoking cognitions: a study among non-smoking adolescents in four Dutch cities.Addiction (Abingdon, England) · 2023Article
- Reducing the number and types of tobacco retail outlets in the Netherlands: Study protocol for a comprehensive mixedmethods policy evaluation.Tobacco prevention & cessation · 2023Article
- Retail endgame strategies: reduce tobacco availability and visibility and promote health equity.Tobacco control · 2022Article
- Drawing on Adolescent Psychology to Achieve Tobacco-Free Generations.Public health reviews · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tobacco retailer licencing has been recommended as an effective tobacco control strategy. In most European countries, however, retailers do not need a licence to sell tobacco products. We aimed to stimulate a discussion on the potential for tobacco retail licencing in Europe by describing (1) potential public health benefits, (2) licencing methods and (3) barriers and success factors in adoption of licencing systems. There is limited scientific evidence, but tobacco retail licencing may reduce smoking in three ways: (1) improved enforcement of and compliance to existing point-of-sale tobacco control policies (eg, minimum age of sale), (2) a reduction in the number and/or density of tobacco retail outlets and (3) denormalisation of tobacco. Licencing systems may take diverse forms. Systems may make licences expensive, and set criteria for purchasing a licence and retaining the licence after first purchase. In Europe, licencing systems have been implemented in Finland, Hungary, France, Italy and Spain. Licencing in Finland and Hungary was adopted for public health reasons; in Finland, with strong public support. In France, Italy and Spain, tobacco sales were state-monopolised, driven by economic motives. The cases of Norway and Scotland show that adoption of retail licencing may fail when political support is insufficient and tobacco retailers organise opposition with support from the tobacco industry. In conclusion, tobacco retailer licencing is a promising method to contribute to tobacco control efforts. Placing tobacco retailer licencing in a child protection framework may help generate the strong political and public support needed to effectively adopt licencing systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.